US2005035177A1PendingUtilityA1

Method for preparing colloidal solution of bismuth sodium tartrate

Assignee: GASTROPAL PARTNERSPriority: Apr 12, 2000Filed: Apr 26, 2004Published: Feb 17, 2005
Est. expiryApr 12, 2020(expired)· nominal 20-yr term from priority
C07F 9/94A61K 31/29A61K 33/245A61K 9/0095A61K 31/191
39
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A method for preparation of a semitransparent colloidal solution of bismuth sodium tartrate generally comprises producing an aqueous solution of bismuth sodium tartrate; extracting a magma of bismuth sodium tartrate from the aqueous solution at a pH of approximately 2.2; and then dissolving the magma into a salting-in mixture. After addition of preservative and strength testing, the base solution is diluted to elixir strength. The elixir is then buffered to a pH range of about 7.2 to about 7.3 in order to maintain for an extended duration the semitransparent nature of the elixir.

Claims

exact text as granted — not AI-modified
1 - 21 . (canceled)  
   
   
       22 . A composition of matter comprising a stable, semitransparent solution of bismuth.  
   
   
       23 . The composition of matter as set forth in  claim 22 , said solution further comprising an active ingredient.  
   
   
       24 . The composition of matter as set forth in  claim 23 , wherein said semitransparency is sufficient to allow testing for strength of said active ingredient.  
   
   
       25 . The composition of matter as set forth in  claim 23 , wherein said active ingredient comprises bismuth trioxide.  
   
   
       26 . A stable, semitransparent solution comprising bismuth.  
   
   
       27 . The composition of matter as set forth in  claim 26 , said solution further comprising an active ingredient.  
   
   
       28 . The composition of matter as set forth in  claim 27 , wherein said semitransparency is sufficient to allow testing for strength of said active ingredient.  
   
   
       29 . The composition of matter as set forth in  claim 27 , wherein said active ingredient comprises bismuth trioxide.  
   
   
       30 . A stable, semitransparent solution of bismuth that is fit for human consumption.

Join the waitlist — get patent alerts

Track US2005035177A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.